(1,2,3-trimethyl-1H-indol-7-yl)-methanol | 1090904-09-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (1,2,3-trimethyl-1H-indol-7-yl)-methanol
• 英文别名: (1,2,3-trimethylindol-7-yl)methanol
• CAS: 1090904-09-8
• 化学式: C₁₂H₁₅NO
• 分子量: 189.257
• InChiKey: ZIKNMCCCFZESCW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  25.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (1,2,3-trimethyl-1H-indol-7-yl)-methanol 、 ethyl 3-(2-oxo-3H-benzimidazol-1-yl)propanoate 在 偶氮二甲酸二异丙酯 、 水 、 三苯基膦 、 lithium hydroxide 作用下， 以 四氢呋喃 、 1,4-二氧六环 为溶剂， 生成 3-{2-oxo-3-[(1,2,3-trimethyl-1H-indol-7-yl)methyl]-2,3-dihydro-1H-benzimidazol-1-yl}propanoic acid
  参考文献：
  名称：

  Benzimidazolone as potent chymase inhibitor: Modulation of reactive metabolite formation in the hydrophobic (P1) region

  摘要：

  A new class of chymase inhibitor featuring a benzimidazolone core with an acid side chain and a P-1 hydrophobic moiety is described. Incubation of the lead compound with GSH resulted in the formation of a GSH conjugate on the benzothiophene P-1 moiety. Replacement of the benzothiophene with different heterocyclic systems such as indoles and benzoisothiazole is feasible. Among the P-1 replacements, benzoisothiazole prevents the formation of GSH conjugate and an in silico analysis of oxidative potentials agreed with the experimental outcome. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.05.126
• 作为产物：
  描述：

  2,3-二甲基-1H-吲哚-7-甲醛 在 sodium tetrahydroborate 、 sodium hydride 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 (1,2,3-trimethyl-1H-indol-7-yl)-methanol
  参考文献：
  名称：

  Benzimidazolone as potent chymase inhibitor: Modulation of reactive metabolite formation in the hydrophobic (P1) region

  摘要：

  A new class of chymase inhibitor featuring a benzimidazolone core with an acid side chain and a P-1 hydrophobic moiety is described. Incubation of the lead compound with GSH resulted in the formation of a GSH conjugate on the benzothiophene P-1 moiety. Replacement of the benzothiophene with different heterocyclic systems such as indoles and benzoisothiazole is feasible. Among the P-1 replacements, benzoisothiazole prevents the formation of GSH conjugate and an in silico analysis of oxidative potentials agreed with the experimental outcome. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.05.126

文献信息

• Benzimidazolone Chymase Inhibitors
  申请人：Abeywardane Asitha

  公开号：US20100240702A1

  公开（公告）日：2010-09-23

  Disclosed are small molecule inhibitors which are useful in treating various diseases and conditions involving chymase.

  公开了一种小分子抑制剂，其在治疗涉及chymase的各种疾病和病况方面是有用的。
• Benzimidazolone chymase inhibitors
  申请人：Abeywardane Asitha

  公开号：US09150556B2

  公开（公告）日：2015-10-06

  Disclosed are small molecule inhibitors which are useful in treating various diseases and conditions involving chymase.

  本发明揭示了一种小分子抑制剂，可用于治疗涉及痰蛋白酶的各种疾病和病况。
• WO2008/147697
  申请人：——

  公开号：——

  公开（公告）日：——
• BENZIMIDAZOLONE CHYMASE INHIBITORS
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP2152674B1

  公开（公告）日：2011-08-03
• US9150556B2
  申请人：——

  公开号：US9150556B2

  公开（公告）日：2015-10-06